Grant: Idea to Innovation
University of Calgary
$20,000.00
Commercialization of a cell-manufacturing process optimization service - Lab2Market (Market assessment)
FY 2021-22
Summary
Cell-based therapies are poised to revolutionize healthcare around the world. Promising to cure chronic diseases, and fully repair damaged tissues and organs, demand for these treatments will be tremendous - as will the costs. While the first few cell-based treatments have entered Canadian health care market, the massive price tag serves as a bottleneck for the uptake of treatments by doctors, patents and the government. In some cases, the cost-of-goods alone for cell manufacturing is estimated to be in the tens and even hundreds of thousands of dollars per dose per patient. Effective, curative treatments may not see the light of day if they are not economically viable. The cost of cell manufacturing must come down to make cell therapies accessible. Over the past several years, we have engineered a biomedical platform integrating scalable cell culture, advanced statistical methods and Machine Learning, and robotic systems to systematically optimize cell manufacturing processes, making them cheaper, faster, and more robust. Our secondary market research indicates a strong need for the cell manufacturing process optimization service. The requested funds for a Market Assessment via a Lab 2 Market program will allow us to focus on primary market research to confirm, expand, or disprove our marketing plan assumptions, and to develop a detailed strategy for the commercialization of our platform.
Program
Idea to Innovation
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
571234-2022
Name nom
Ungrin, Mark
Department département
Veterinary Medicine, Faculty of
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2022
Award amount
20000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
1
Application title
Commercialization of a cell-manufacturing process optimization service - Lab2Market (Market assessment)
Keyword
NSERC
Application summary
Cell-based therapies are poised to revolutionize healthcare around the world. Promising to cure chronic diseases, and fully repair damaged tissues and organs, demand for these treatments will be tremendous - as will the costs. While the first few cell-based treatments have entered Canadian health care market, the massive price tag serves as a bottleneck for the uptake of treatments by doctors, patents and the government. In some cases, the cost-of-goods alone for cell manufacturing is estimated to be in the tens and even hundreds of thousands of dollars per dose per patient. Effective, curative treatments may not see the light of day if they are not economically viable. The cost of cell manufacturing must come down to make cell therapies accessible. Over the past several years, we have engineered a biomedical platform integrating scalable cell culture, advanced statistical methods and Machine Learning, and robotic systems to systematically optimize cell manufacturing processes, making them cheaper, faster, and more robust. Our secondary market research indicates a strong need for the cell manufacturing process optimization service. The requested funds for a Market Assessment via a Lab 2 Market program will allow us to focus on primary market research to confirm, expand, or disprove our marketing plan assumptions, and to develop a detailed strategy for the commercialization of our platform.